-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J4TWbLrRcoFwn/C94sEh2pER0U6EWsTkHdES1a9rCzN8xEpmugB7vQ1BwFwA+oMD Mj+aanaFruGtq+Tyc8LvQg== 0001209191-04-043695.txt : 20040908 0001209191-04-043695.hdr.sgml : 20040908 20040908160506 ACCESSION NUMBER: 0001209191-04-043695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040907 FILED AS OF DATE: 20040908 DATE AS OF CHANGE: 20040908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIOTTA GREGORY J CENTRAL INDEX KEY: 0001235860 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 041020839 BUSINESS ADDRESS: STREET 1: ONYX PHARMACEUTICALS INC STREET 2: 3031 RESARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3031 RESEARCH DR STREET 2: BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 MAIL ADDRESS: STREET 1: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-09-07 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235860 GIOTTA GREGORY J C/O ONYX PHARMACEUTICALS, INC. 3031 RESEARCH DRIVE, BLDG. A RICHMOND CA 94806 0 1 0 0 VP & Chief Legal Counsel Common Stock 2004-09-07 4 M 0 2500 4.87 A 2500 D Common Stock 2004-09-07 4 M 0 2604 4.00 A 5104 D Common Stock 2004-09-07 4 M 0 4896 5.00 A 10000 D Common Stock 2004-09-07 4 S 0 974 40.81 D 9026 D Common Stock 2004-09-07 4 S 0 3626 41.00 D 5400 D Common Stock 2004-09-07 4 S 0 5400 41.03 D 0 D Stock Option (Right to Buy) 4.87 2004-09-07 4 D 0 2500 0.00 D 2002-06-06 2011-11-05 Common Stock 2500 5833 D Stock Option (Right to Buy) 4.00 2004-09-07 4 D 0 2604 0.00 D 2003-01-22 2012-07-21 Common Stock 2604 11979 D Stock Option (Right to Buy) 5.00 2004-09-07 4 D 0 4896 0.00 D 2003-08-12 2013-02-11 Common Stock 4896 19979 D The shares subject to the option become exercisable at a rate of 12.5% on the date 6 months following the date of grant and in equal monthly installments thereafter for the following 42 months. /s/ Marilyn E. Wortzman, Attorney-in-fact 2004-09-07 -----END PRIVACY-ENHANCED MESSAGE-----